Bunion Surgery Market

Market Definition

The market covers medical procedures aimed at correcting hallux valgus, a foot deformity where the big toe deviates toward the other toes, causing pain and functional issues. 

This market includes various surgical techniques such as osteotomy, exostectomy, and arthrodesis, along with associated devices like implants, fixation systems, and surgical tools. The report highlights key market drivers, major trends, regulatory frameworks, and the competitive landscape shaping the industry’s growth.

Bunion Surgery Market Overview

The bunion surgery market size was valued at USD 783.7 million in 2023 and is projected to grow from USD 823.5 million in 2024 to USD 1232.1 million by 2031, exhibiting a CAGR of 5.92% during the forecast period. 

This growth is driven by the rising prevalence of bunions, increasing preference for minimally invasive procedures, and growing awareness regarding foot health and early surgical intervention. Increasing awareness of early intervention advantages and advancements in surgical technologies, such as minimally invasive procedures, are further driving the market.

Major companies operating in the bunion surgery industry are Astrolabe, Zimmer Biomet, Extremity Medical, Paragon 28, Inc., BioPro, Inc, CONMED Corporation, Acumed, Treace Medical Concepts, Inc., Voom, Medartis AG, Stryker, Deva Tibbi, Arthrex, Inc., Johnson & Johnson Services, Inc., and Enovis Corporation.

Additionally, the development of innovative fixation systems and implants designed for quicker recovery is playing a crucial role in driving the adoption of bunion surgery procedures. Advances in minimally invasive techniques have led to the introduction of advanced internal fixation systems, such as bioabsorbable screws and plates, which offer improved stability while reducing the need for extensive post-operative care.

• In April 2024, RELJA Innovations introduced the RELJA Clamp, a radiolucent single-use device designed for bunion reduction. Featuring a simple and intuitive application process that takes under four minutes, the RELJA Clamp is primarily used for the Bunion Procedure. It is also compatible with MIS Bunion Procedures, Midfoot and Hindfoot Fusions, and Lisfranc Fracture Reductions.

Key Highlights

1. The bunion surgery market size was recorded at USD 783.7 million in 2023.
2. The market is projected to grow at a CAGR of 5.92% from 2024 to 2031.
3. North America held a market share of 35.95% in 2023, with a valuation of USD 281.7 million.
4. The systems segment garnered USD 424.3 million in revenue in 2023.
5. The adult segment is expected to reach USD 758.4 million by 2031.
6. The minimally invasive surgery segment is expected to reach USD 713.8 million by 2031.
7. The hospitals segment is expected to reach USD 493.4 million by 2031.
8. Asia Pacific is anticipated to grow at a CAGR of 6.78% during the forecast period.

Market Driver

Rising Prevalence of Bunion

The market is expanding due to the rising prevalence of bunions among adult and elderly populations. This increase is primarily driven by age-related changes in foot structure, prolonged weight-bearing stress, and the continued use of narrow or ill-fitting footwear. 

As the global population ages, the number of individuals experiencing pain, joint misalignment, and mobility challenges from bunions continues to rise. This has resulted in a higher volume of patients seeking surgical intervention to relieve symptoms and restore foot function.

• In September 2023, according to a research by Guangzhou University of Chinese Medicine, the global incidence and prevalence of bunion were examined in terms of its spatial, temporal, and population distribution. The study revealed that the global estimated pooled prevalence of bunion was 19%, with a higher prevalence found in females (23.74%).

Market Challenge

Limited Access to Skilled Orthopedic Surgeons

One of the major challenges in the global bunion surgery market is the limited access to skilled orthopedic surgeons, especially in rural and low-resource settings. Bunion surgeries require precise techniques and specialized training, particularly for minimally invasive procedures. 

In many regions, such as Sub-Saharan Africa, Southeast Asia, and Latin America there is a shortage of trained professionals, which restricts the availability of advanced surgical options and delays treatment. This gap affects patient outcomes and limits market expansion in underserved areas. 

A potential solution is the implementation of targeted training programs and international education initiatives. Partnerships between medical device companies and healthcare institutions can support surgeon training through workshops, digital platforms, and global outreach programs. These efforts can help expand the reach of quality bunion care and support the market’s long-term growth.  

Market Trend

Technological Advancements in Surgical Systems and Fixation Devices

The global market is experiencing a trend driven by technological advancements in surgical systems and fixation devices. These innovations are enhancing the precision of bunion surgery, allowing for more accurate procedures with reduced complication rates. 

With the introduction of cutting-edge tools, such as 3D imaging, robotic-assisted surgery, and advanced fixation devices, surgeons are able to perform more effective and less invasive surgeries. This trend not only improves surgical outcomes but also contributes to quicker recovery times, encouraging greater adoption of bunion surgery among patients. 

The advancements are particularly valued in minimally invasive procedures, which are becoming increasingly popular for their reduced risk and shorter healing periods.

• In September 2023, stryker launched the PROstep MIS Lapidus, a minimally invasive internal fixation system for bunion treatment. the system is designed for surgical correction of hallux valgus commonly known as bunion deformity and fusion of the first metatarsal cuneiform joint.

Bunion Surgery Market Report Snapshot

Segmentation	Details
By Product	Systems, Consumables
By Patient	Adult, Pediatric
By Type	Minimally Invasive Surgery, Traditional Surgery
By End User	Hospitals, Orthopedic Clinics, Others
By Region	North America: U.S., Canada, Mexico
	Europe: France, UK, Spain, Germany, Italy, Russia, Rest of Europe
	Asia-Pacific: China, Japan, India, Australia, ASEAN, South Korea, Rest of Asia-Pacific
	Middle East & Africa: Turkey, U.A.E., Saudi Arabia, South Africa, Rest of Middle East & Africa
	South America: Brazil, Argentina, Rest of South America

 Market Segmentation

• By Product (Systems, Consumables): The systems segment earned USD 424.3 million in 2023 due to the growing demand for advanced surgical platforms that improve precision and reduce recovery time.
• By Patient (Adult, Pediatric): The adult held 62.15% of the market in 2023, due to the higher prevalence of bunions in the aging population.
• By Type (Minimally Invasive Surgery, Traditional Surgery): The minimally invasive surgery segment is projected to reach USD 713.8 million by 2031, owing to patient preference for shorter recovery periods and less postoperative pain.
• By End User (Hospitals, Orthopedic Clinics, Others): The hospitals segment is projected to reach USD 493.4 million by 2031, owing to the availability of specialized surgical teams and comprehensive care facilities.

Bunion Surgery Market Regional Analysis

Based on region, the global market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

North America bunion surgery market share stood around 35.95% in 2023 in the global market, with a valuation of USD 281.7 million. The dominance is due to the well-established healthcare infrastructure and widespread access to specialized orthopedic care. High awareness of foot-related conditions among patients has led to early diagnosis and timely surgical intervention. 

The presence of major medical device manufacturers and the widespread use of advanced surgical systems have accelerated the introduction of innovative techniques and technologies. 

In addition, expanding education and training programs for orthopedic surgeons are improving surgical outcomes and accelerating the adoption of advanced bunion correction techniques, thereby driving the market in this region.

• In February 2024, Steps2Walk, based out of Denver, U.S., launched the Steps2Walk Global Institute to expand education and training in foot and ankle care for orthopedic surgeons. The initiative aims to deliver sustainable learning programs in underserved regions through local surgeon training, telemedicine mentorship, pediatric care advancement, cadaveric sessions, and volunteer preparation.

Asia Pacific is poised to grow at a significant growth at a CAGR of 6.78% over the forecast period. The growth is due to the increasing geriatric population and changing lifestyle patterns resulting in a higher incidence of bunion deformities. Countries like China, India, and Japan are investing heavily in healthcare infrastructure, leading to improved surgical capabilities and patient access. 

Rising disposable income and expanding health insurance coverage have made elective surgeries more feasible for a broader population base. The growing adoption of advanced technologies and surgeon training initiatives is expected to further drive the market in Asia Pacific in the coming years.

Regulatory Frameworks

• In the U.S., the Food and Drug Administration (FDA) regulates medical devices used in bunion surgery under its Center for Devices and Radiological Health (CDRH). Devices such as implants, screws, plates, and surgical instruments must undergo evaluation for safety and effectiveness.
• In Europe, bunion surgery devices fall under the Medical Device Regulation (MDR 2017/745), which mandates conformity assessment, CE marking, and clinical evaluation. Manufacturers must work with a Notified Body to ensure compliance before commercialization of products.

Competitive Landscape

Companies in the bunion surgery market are focusing on expanding their surgical portfolios through the development of minimally invasive technologies and next-generation fixation systems. Strategic partnerships with orthopedic centers and hospitals are being formed to strengthen distribution networks and enhance clinical adoption. 

Many players are investing in research and development to introduce products that reduce recovery time and improve patient outcomes. Cadaveric training programs and surgeon education initiatives are being implemented to increase awareness and usage of advanced systems. 

In addition, market players are securing regulatory approvals in new geographies to expand their presence in untapped markets. Mergers, acquisitions, and licensing agreements remain key strategies adopted by market players to access new technologies and accelerate product development pipelines.

• In March 2025, Voom Medical Devices, Inc. introduced a next-generation single-use sterile kit with the MIBS CoPilot shift + targeting guide to improve the Bunionplasty 360 Repair Procedure. Showcased at the American College of Foot and Ankle Surgeons Annual Meeting, the kit includes the upgraded Revcon Screw System.

List of Key Companies in Bunion Surgery Market

• Astrolabe
• Zimmer Biomet
• Extremity Medical
• Paragon 28, Inc.
• BioPro, Inc
• CONMED Corporation
• Acumed
• Treace Medical Concepts, Inc.
• Voom
• Medartis AG
• Stryker
• Deva Tibbi
• Arthrex, Inc.
• Johnson & Johnson Services, Inc.
• Enovis Corporation

Recent Developments (Product Launch)

• In December 2024, Treace Medical Concepts, Inc. revealed the limited market release of its Percuplasty Percutaneous 3D Bunion Correction Procedure. The Percuplasty offers a minimally invasive, instrumented approach to 3D bunion correction. It is designed to reduce post-operative pain and swelling, allowing patients to return to active lifestyles quickly.